Biomedicines (Apr 2022)

The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives

  • Panagiotis D. Papadopoulos,
  • Christina Tsigalou,
  • Pipitsa N. Valsamaki,
  • Theocharis G. Konstantinidis,
  • Chrysoula Voidarou,
  • Eugenia Bezirtzoglou

DOI
https://doi.org/10.3390/biomedicines10050948
Journal volume & issue
Vol. 10, no. 5
p. 948

Abstract

Read online

The collection of normally non-pathogenic microorganisms that mainly inhabit our gut lumen shapes our health in many ways. Structural and functional perturbations in the gut microbial pool, known as “dysbiosis”, have been proven to play a vital role in the pathophysiology of several diseases, including cardiovascular disease (CVD). Although therapeutic regimes are available to treat this group of diseases, they have long been the main cause of mortality and morbidity worldwide. While age, sex, genetics, diet, tobacco use, and alcohol consumption are major contributors (World Health Organization, 2018), they cannot explain all of the consequences of CVD. In addition to the abovementioned traditional risk factors, the constant search for novel preventative and curative tools has shed light on the involvement of gut bacteria and their metabolites in the pathogenesis of CVD. In this narrative review, we will discuss the established interconnections between the gut microbiota and CVD, as well as the plausible therapeutic perspectives.

Keywords